Growth Opportunities in the US Point-of-care Testing Market
The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and market share analyses in each of these segments provide a thorough understanding of the competitive landscape. The analysis provides predictions on the future of the POCT market segments and key areas of investment that should be in the planning books for in vitro diagnostic device (IVD) companies operating in the POCT space.
Electronic Access - Site License Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher